QbD-Optimized QuercetinNanoparticulate Ophthalmic Systems for Diabetic Retinopathy: Suspension Versus In-Situ Gel
Crossref DOI link: https://doi.org/10.1007/s12247-026-10732-6
Published Online: 2026-05-13
Published Print: 2026-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sahu, Geetanjali
Das Paul, Swarnali https://orcid.org/0000-0001-8044-4143
Text and Data Mining valid from 2026-05-13
Version of Record valid from 2026-05-13
Article History
Received: 6 February 2026
Accepted: 5 May 2026
First Online: 13 May 2026
Declarations
:
: The authors declare no competing interests.